News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Davis R M Inc. increased its stake in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by 4.3% in the first quarter, now owning 255,075 shares valued at over $50 million. Other institutional investors also adjusted their positions in the company. Analysts hold a "Moderate Buy" consensus …
Sharemaestro market context Trend signal active 52 weeks -2.8%Andra AP fonden has acquired a new position in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) during the first quarter, purchasing 32,000 shares valued at approximately $6.32 million. Other institutional investors also adjusted their holdings in the company, which saw its stock trading down 1.0% at …
SEB Asset Management AB has invested $8.65 million in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by purchasing 43,786 shares in the first quarter. This article also details other institutional investor activity, significant insider stock sales by company executives, and recent analyst ratings which generally recommend …
India has approved Takeda Pharmaceutical's dengue vaccine, making it the country's first such vaccine. This move aims to tackle the dramatic increase in dengue cases in India, which have soared elevenfold over the past two decades. The approval by Indian regulators is a significant …
This article provides an AI-generated analysis of Take-two Interactive Software Inc. (NASDAQ: TTWO), highlighting weak near and mid-term sentiment but a neutral long-term outlook. It details three trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The report also …
Jennison Associates LLC reduced its stake in Take-Two Interactive Software (NASDAQ:TTWO) by 8.2% in the first quarter, selling 20,788 shares and retaining 231,409 shares valued at $45.7 million. Despite institutional selling, analysts generally maintain a "Moderate Buy" rating with an average price target of …
Sharemaestro market context Trend signal active 52 weeks -2.8%DJE Kapital AG initiated a new position in Take-Two Interactive Software (NASDAQ:TTWO) during the first quarter, acquiring shares worth approximately $9.99 million. This investment highlights continued institutional interest in TTWO, with several large funds increasing their stakes. Analyst sentiment for the stock is generally …
The California Public Employees Retirement System (CalPERS) reduced its stake in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by 24.2% in the first quarter, selling 76,189 shares and holding 238,705 shares valued at $47.14 million. This move is part of broader institutional trading activity, with other …
This article analyzes Roblox (RBLX) and Take-Two Interactive Software (TTWO) to determine which gaming stock presents a stronger investment case. Roblox is highlighted for its expanding user engagement, creator economics, and AI capabilities, despite a lowered full-year bookings outlook. Take-Two faces an uneven fiscal …
Novartis' Tafinlar and Takeda's Adcetris in combination with bendamustine have gained routine use on the NHS for rare blood cancers, benefiting approximately 200 patients annually. These drugs offer additional therapeutic options, particularly for cases where other treatments have failed, and align with the UK’s …
Takeda Pharmaceutical Company L (NYSE: TAK) presents a strong investment opportunity in the healthcare sector, backed by a robust market capitalization, diverse product portfolio, and attractive 3.60% dividend yield. Despite some negative financial metrics like EPS and ROE, its $672.78 billion free cash flow …
Take-Two Interactive is projected for significant growth in fiscal year 2027, with net bookings guided to $8 billion to $8.2 billion, a 20% increase, primarily driven by the confirmed November 19 release of Grand Theft Auto VI. Despite this optimistic outlook and strong analyst …
Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making it the first such vaccine cleared in the country. This two-dose vaccine is effective against all four dengue virus serotypes and is indicated for ages 4 to 60, with high efficacy …
Mediolanum International Funds Ltd increased its stake in Take-Two Interactive Software, Inc. (NASDAQ:TTWO) by 41.0% in the first quarter, now owning 279,609 shares valued at $53,987,000. Other hedge funds also adjusted their holdings, and institutional investors collectively own 95.46% of the stock. Meanwhile, company …
Sharemaestro market context Trend signal active 52 weeks -2.8%Bank of New York Mellon Corp decreased its stake in Take-Two Interactive Software by 6.6% in the first quarter, selling 66,779 shares. Despite this, institutional ownership remains high at 95.46%, with several other institutional investors increasing their holdings. Wall Street analysts have a "Moderate …
Jefferies analysts highlight that investor sentiment for Take-Two Interactive Software (TTWO) is now primarily driven by the timing and scope of Grand Theft Auto VI (GTA VI), particularly its online component, rather than near-term quarterly performance. This focus on GTA VI's launch plans could …
Sharemaestro market context Trend signal active 52 weeks +7.8%STAK Inc. experienced significant downside pressure and high volatility, with its stock trading down by -48.88% after a major product recall. The company's financials indicate a micro-cap energy name with modest scale and unproven profitability, leading to a depressed valuation. Technically, the stock shows …
STAK Inc. stock experienced a sharp drop of 48.88% due to heightened volatility and regulatory probes, trading significantly below recent highs. The micro-cap energy company, with revenues of $24.9M and a low price-to-sales ratio, exhibits tight liquidity and high operational execution risk. Analysts suggest …
Takeda Pharmaceutical Company reported strong FY2024 results with core revenue growth of 2.8% and a 4.9% increase in core operating profit at constant exchange rates, driven by growth and launch products. The company also announced an increased dividend of JPY 200 per share and …
STAK Inc. stock is experiencing significant volatility, with intensified selling pressure following a regulatory probe, causing a -14.8% drop. Despite sharp pullbacks from early-month highs, the stock is holding above recent lows, characterized by whipsaw action and rapid price swings. Active traders are closely …
Takeda Pharmaceutical's recent Phase 3 data for its psoriasis drug zasocitinib and plans for FDA filing have put the stock back in the spotlight. Despite a strong performance with over 31% shareholder return in the past year, the company's shares are still considered undervalued …
Sharemaestro market context Price above Trend Line 52 weeks +27.3%Photo by BeInCrypto Take-Two Interactive confirmed GTA VI's release date in a formal SEC filing.The preliminary proxy statement set November 19, 2026, and framed fiscal 2027 as a turning point. CEO Strauss Zelnick called the coming year a major inflection point. He cited record …
Sharemaestro market context Trend signal active 52 weeks -2.8%STAK Inc. shares are trading over 60% higher on Thursday, attempting a rebound from a recent pullback, while still maintaining a longer-term uptrend. The company also announced plans to form a U.S. subsidiary to commercialize modular gas-to-electricity generation systems for AI data centers. STAK …
Take-Two Interactive Software (TTWO) has filed its proxy statement, summarizing a strong Fiscal 2026 with $6.72B in Net Bookings, driven by titles like NBA 2K and Grand Theft Auto. Fiscal 2027 is projected to be a major inflection point with the release of Grand …
Take-Two Interactive is expected to report an in-line first fiscal quarter, with investor attention primarily focused on updates regarding Grand Theft Auto VI (GTA VI). Jefferies analysts anticipate muted expectations for the quarter, largely due to weakness in the company's mobile business, but maintain …
Takeda Pharmaceutical's oral psoriasis drug, zasocitinib, showed strong skin clearance in Phase 3 trials, with approximately 70% of patients achieving clear or nearly clear skin within 16 weeks, including in difficult-to-treat areas like the scalp and nails. The drug demonstrated rapid and sustained improvements …
STAK Inc. is experiencing significant selling pressure, with its stock down 27.38% after a critical regulatory setback. The stock has dropped from early-July highs above $4.50 to around $2.60, indicating aggressive selling and rising volatility. While its valuation appears discounted, STAK's balance sheet shows …
Takeda Pharmaceutical Company announced positive secondary endpoint data from two Phase 3 studies of zasocitinib, an investigational oral therapy for moderate-to-severe plaque psoriasis, at the American Academy of Dermatology Innovation Academy. The results showed significant improvements in scalp and palmoplantar psoriasis compared to placebo. …
Take-Two Interactive Software (TTWO) is under scrutiny after a share price decline and trimmed earnings estimates, despite strong long-term shareholder returns. Analysts believe the stock is currently undervalued, with a fair value of $276.97, largely anticipating a significant earnings boost from GTA VI. However, …
Sharemaestro market context Trend signal active 52 weeks -2.8%STAK Inc. (STAK) saw its stock price jump 88.3% due to investor excitement over its expansion into AI-linked distributed power systems and new energy vehicles (NEV). The company announced plans to form a subsidiary for modular gas-to-electricity generation systems targeting AI data centers and …
Takeda Pharmaceutical announced it will host an earnings call on July 30, 2026, to present its first-quarter results for fiscal year 2026. Key participants will include President and CEO Julie Kim, CFO Milano Furuta, and President of R&D Andy Plump. The event will be …
Search by ticker symbol or company name and select a result to open its chart. The US only control limits results to active US-listed stocks and ETFs.
Showing active US-listed stocks and ETFs only.